Wei Wang

Wei Wang

Auto-generated profile, based on publicly available information

Wei Wang

Department of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Science Advances
Verified
Journal Article
Open access
ZHZhaohuan Huang
Zhaohuan Huang
LLLing Liu
Ling Liu
JZJian Zhang
Jian Zhang
KCKristine Conde
Kristine Conde
JPJay Phansalkar
Jay Phansalkar
JLJi Liu
Ji Liu
Glucagon-like peptide-1 (GLP-1) regulates energy homeostasis via activation of the GLP-1 receptors (GLP-1Rs) in the central nervous system. However, the mechanism by which the central GLP-1 signal controls blood glucose levels, especially in different nutrient states, remains unclear. Here, we defined a population of glucose-sensing GLP-1R neurons in the dorsomedial hypothalamic nucleus (DMH), by which endogenous GLP-1 decreases glucose levels via the cross-talk between the hypothalamus and pancreas. Specifically, we illustrated the sufficiency and necessity of DMH GLP-1R in glucose regulation. The activation of the DMH GLP-1R neurons is mediated by a cAMP-PKA–dependent inhibition of a delayed rectifier potassium current. We also dissected a descending control of DMH GLP-1R –dorsal motor nucleus of the vagus nerve (DMV)–pancreas activity that can regulate glucose levels by increasing insulin release. Thus, our results illustrate how central GLP-1 action in the DMH can induce a nutrient state–dependent reduction in blood glucose level.

1 February 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
WWWei Wang
Wei Wang
BDBo Duan
Bo Duan
HXHan Xu
Han Xu
LXLin Xu
Lin Xu
TXTian-Le Xu
Tian-Le Xu
Acid-sensing ion channels (ASICs) are emerging as fundamental players in the regulation of neural plasticity and in pathological conditions. Here we showed that lead (Pb2+), a well known neurotoxic metal ion, reversibly and concentration-dependently inhibited ASIC currents in the acutely dissociated spinal dorsal horn and hippocampal CA1 neurons of rats. In vitro expression of ASIC subunits in combination demonstrated that both ASIC1 and -3 subunits were sensitive to Pb2+. Mechanistically, Pb2+ reduced the pH sensitivity of ASICs independent of membrane voltage change. Moreover, Pb2+ inhibited the ASIC-mediated membrane depolarization and the elevation of intracellular Ca2+ concentration. In addition, we compared the effect of Pb2+ with that of Ca2+ or amiloride to explore the possible interactions of Pb2+ and Ca2+ in regulating ASICs, and we found that Pb2+ inhibited ASIC currents independent of the amiloride/Ca2+ blockade. Because ASIC1b and -3 subunits are mainly expressed in peripheral neurons, our data identified ASIC1a-containing Ca2+-permeable ASIC as a novel central target of Pb2+ action, which may contribute to Pb2+ neurotoxicity.

1 March 2009 in Neuroscience
Verified
Journal Article
Closed access
QMQ.-Y. Meng
Q.-Y. Meng
WWW. Wang
W. Wang
XCX.-N. Chen
X.-N. Chen
TXT.-L. Xu
T.-L. Xu
JZJ.-N. Zhou
J.-N. Zhou

25 January 2023 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
PDF file
ZSZi-Hua Song
Zi-Hua Song
XSXiang-Jie Song
Xiang-Jie Song
CYChen-Ling Yang
Chen-Ling Yang
PCPeng Cao
Peng Cao
YMYu Mao
Yu Mao
WTWenjuan Tao
Wenjuan Tao
Diabetic patients frequently experience neuropathic pain, which currently lacks effective treatments. The mechanisms underlying diabetic neuropathic pain remain unclear. The anterior cingulate cortex (ACC) is well-known to participate in the processing and transformation of pain information derived from internal and external sensory stimulation. Accumulating evidence shows that dysfunction of microglia in the central nervous system contributes to many diseases, including chronic pain and neurodegenerative diseases. In this study, we investigated the role of microglial chemokine CXCL12 and its neuronal receptor CXCR4 in diabetic pain development in a mouse diabetic model established by injection of streptozotocin (STZ). Pain sensitization was assessed by the left hindpaw pain threshold in von Frey filament test. Iba1+ microglia in ACC was examined using combined immunohistochemistry and three-dimensional reconstruction. The activity of glutamatergic neurons in ACC (ACCGlu) was detected by whole-cell recording in ACC slices from STZ mice, in vivo multi-tetrode electrophysiological and fiber photometric recordings. We showed that microglia in ACC was significantly activated and microglial CXCL12 expression was up-regulated at the 7-th week post-injection, resulting in hyperactivity of ACCGlu and pain sensitization. Pharmacological inhibition of microglia or blockade of CXCR4 in ACC by infusing minocycline or AMD3100 significantly alleviated diabetic pain through preventing ACCGlu hyperactivity in STZ mice. In addition, inhibition of microglia by infusing minocycline markedly decreased STZ-induced upregulation of microglial CXCL12. Together, this study demonstrated that microglia-mediated ACCGlu hyperactivity drives the development of diabetic pain via the CXCL12/CXCR4 signaling, thus revealing viable therapeutic targets for the treatment of diabetic pain.

1 March 2007 in Neuroscience
Verified
Journal Article
Closed access
WWW. Wang
W. Wang
YYY. Yu
Y. Yu
TXT.-L. Xu
T.-L. Xu

12 September 2016 in Journal of Diabetes
Verified
Journal Article
Closed access
PDF file
LZLimin Zhai
Limin Zhai
JGJunfei Gu
Junfei Gu
DYDi Yang
Di Yang
WHWen Hu
Wen Hu
WWWei Wang
Wei Wang
SYShandong Ye
Shandong Ye